Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The British Journal of Dermatology|February 3, 2009
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factorsC Sunderkötter, I Herrgott, C Brückner, et al.
Arthritis and Rheumatism|May 28, 2010
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosisJ R Seibold, C P Denton, D E Furst, et al.
Annals of the Rheumatic Diseases|July 27, 2006
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk testM H Buch, C P Denton, D E Furst, et al.
Annals of the Rheumatic Diseases|June 3, 2006
Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patientsY Allanore, D Borderie, P Airo, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian populationP Dieudé, M Guedj, J Wipff, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010]E Grünig, A Barner, M Bell, et al.
Zeitschrift Fur Rheumatologie|May 20, 2016
[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)]G Riemekasten, M Aringer, C G O Baerwald, et al.
Arthritis and Rheumatism|October 31, 2009
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4P Dieudé, J Wipff, M Guedj, et al.
Genes and Immunity|May 4, 2012
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosisC McKinney, J C A Broen, M C Vonk, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]H A Ghofrani, O Distler, F Gerhardt, et al.
Pageof 9